Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Keating

Showing results (1001-1010 of 1,115) with videos related to

Pageof 112
Sort By:
British Journal of Haematology|November 23, 2017
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximabPreetesh Jain, Graciela M Nogueras González, Rashmi Kanagal-Shamanna, et al.
Human Genetics|December 15, 2010
Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African AmericansKen Sin Lo, James G Wilson, Leslie A Lange, et al.
Journal of Lipid Research|July 23, 2015
Genetic meta-analysis of 15,901 African Americans identifies variation in EXOC3L1 is associated with HDL concentrationMatthew B Lanktree, Clara C Elbers, Yun Li, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 3, 2020
Risk of pre-eclampsia in patients with a maternal genetic predisposition to common medical conditions: a case-control studyK J Gray, V P Kovacheva, H Mirzakhani, et al.
Oncogene|August 11, 2010
Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effectsG M Marshall, S Gherardi, N Xu, et al.
Blood|August 10, 2007
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemiaGabrielle S Sellick, Lynn R Goldin, Ruth W Wild, et al.
Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Human Molecular Genetics|January 4, 2015
Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemiaMinal J Menezes, Yiran Guo, Jianguo Zhang, et al.
Blood|December 12, 2018
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemiaJan A Burger, Mariela Sivina, Nitin Jain, et al.
Pageof 112

Showing results (1001-1010 of 1,115) with videos related to

Sort By:
Pageof 112
British Journal of Haematology|November 23, 2017
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximabPreetesh Jain, Graciela M Nogueras González, Rashmi Kanagal-Shamanna, et al.
Human Genetics|December 15, 2010
Genetic association analysis highlights new loci that modulate hematological trait variation in Caucasians and African AmericansKen Sin Lo, James G Wilson, Leslie A Lange, et al.
Journal of Lipid Research|July 23, 2015
Genetic meta-analysis of 15,901 African Americans identifies variation in EXOC3L1 is associated with HDL concentrationMatthew B Lanktree, Clara C Elbers, Yun Li, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 3, 2020
Risk of pre-eclampsia in patients with a maternal genetic predisposition to common medical conditions: a case-control studyK J Gray, V P Kovacheva, H Mirzakhani, et al.
Oncogene|August 11, 2010
Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effectsG M Marshall, S Gherardi, N Xu, et al.
Blood|August 10, 2007
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemiaGabrielle S Sellick, Lynn R Goldin, Ruth W Wild, et al.
Haematologica|November 10, 2018
The involvement of microRNA in the pathogenesis of Richter syndromeKatrien Van Roosbroeck, Recep Bayraktar, Steliana Calin, et al.
JCI Insight|February 1, 2017
Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinibJan A Burger, Kelvin W Li, Michael J Keating, et al.
Human Molecular Genetics|January 4, 2015
Mutation in mitochondrial ribosomal protein S7 (MRPS7) causes congenital sensorineural deafness, progressive hepatic and renal failure and lactic acidemiaMinal J Menezes, Yiran Guo, Jianguo Zhang, et al.
Blood|December 12, 2018
Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemiaJan A Burger, Mariela Sivina, Nitin Jain, et al.
Pageof 112